Position in TNYA
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$10,380
-$300 QoQ
Shares Held
15,000
0.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#72
of 103 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TNYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026COMMERCE BANK holds $27,782,414 across 24 Biotechnology names. TNYA ranks #24 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
6,448 | $4,981,982 | |
| 2 | EXEL |
Exelixis, Inc.
|
88,824 | $3,809,659 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,535 | $3,364,678 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,480 | $3,136,646 | |
| 5 | MRNA |
Moderna, Inc.
|
48,508 | $2,464,206 | |
| 6 | INCY |
Incyte Corp
|
19,518 | $1,837,033 | |
| 7 | TECH |
BIO-TECHNE Corp
|
34,131 | $1,783,685 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
17,860 | $1,154,291 |
All Filings in TNYA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,380 | 15,000 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $10,680 | 15,000 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $40,500 | 25,000 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $18,330 | 30,000 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $17,100 | 30,000 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $28,600 | 20,000 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||